GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
It's important to take care of them with the correct remedy
It is worth reading more about how the options compare in our guide on which weight-loss treatment is right for you, and about the risks of unregistered products in our note on compounded GLP-1 medications
There are several types of bariatric surgery: Sleeve gastrectomy: In the most-popular procedure, the surgeon removes about 80 percent of your stomach, making it smaller and reducing the hunger hormone ghrelin
Clostridium butyricum (WB-STR-0006) Do not let the name fool you
3 A gradual dose increase helps your body adjust while minimizing potential side effects